Interleukin 6 IL-6 Inhibitors Market Overview
The Interleukin 6 IL-6 Inhibitors Market was valued at USD 4.8 billion in 2024 and is projected to reach USD 15.5 billion by 2035, growing at a robust CAGR of 11.3%. IL-6 inhibitors target the interleukin-6 cytokine pathway, which plays a central role in inflammatory and autoimmune diseases. These biologic therapies have transformed treatment paradigms for conditions such as rheumatoid...
0 Comments 0 Shares 62 Views 0 Reviews